Xingjiang Yu

1.3k total citations
29 papers, 801 citations indexed

About

Xingjiang Yu is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Xingjiang Yu has authored 29 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Immunology and 7 papers in Genetics. Recurrent topics in Xingjiang Yu's work include Glioma Diagnosis and Treatment (7 papers), Immune cells in cancer (4 papers) and RNA Research and Splicing (4 papers). Xingjiang Yu is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Immune cells in cancer (4 papers) and RNA Research and Splicing (4 papers). Xingjiang Yu collaborates with scholars based in China, United States and Mexico. Xingjiang Yu's co-authors include Haidong Huang, Shideng Bao, Jennifer S. Yu, Wenchao Zhou, Lei Li, Zhaohong Yi, Gürkan Bebek, Dandan Qin, Zheng-gang Liu and Hongtao Zhu and has published in prestigious journals such as Nature Communications, Development and Cell stem cell.

In The Last Decade

Xingjiang Yu

29 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingjiang Yu China 14 479 229 174 148 144 29 801
Timothy M. Chlon United States 17 532 1.1× 202 0.9× 109 0.6× 79 0.5× 137 1.0× 32 936
Sietske T. Bakker United States 11 822 1.7× 221 1.0× 143 0.8× 126 0.9× 101 0.7× 13 1.2k
Jerry C. Cheng United States 14 387 0.8× 100 0.4× 108 0.6× 136 0.9× 116 0.8× 28 707
Antonia Boyer United States 8 782 1.6× 212 0.9× 150 0.9× 134 0.9× 37 0.3× 14 1.0k
Olga F. Sarmento United States 13 577 1.2× 280 1.2× 143 0.8× 64 0.4× 25 0.2× 18 867
Anthony A. Fernald United States 18 707 1.5× 114 0.5× 156 0.9× 145 1.0× 174 1.2× 36 1.1k
Karen E. Brown United States 11 736 1.5× 210 0.9× 54 0.3× 76 0.5× 31 0.2× 16 1.1k
William S. Einhorn United States 5 912 1.9× 111 0.5× 548 3.1× 67 0.5× 50 0.3× 6 1.3k
Elizabeth J. Heller United States 6 541 1.1× 253 1.1× 45 0.3× 90 0.6× 41 0.3× 6 856
Eli S. Williams United States 17 442 0.9× 54 0.2× 125 0.7× 235 1.6× 173 1.2× 40 777

Countries citing papers authored by Xingjiang Yu

Since Specialization
Citations

This map shows the geographic impact of Xingjiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingjiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingjiang Yu more than expected).

Fields of papers citing papers by Xingjiang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingjiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingjiang Yu. The network helps show where Xingjiang Yu may publish in the future.

Co-authorship network of co-authors of Xingjiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingjiang Yu. A scholar is included among the top collaborators of Xingjiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingjiang Yu. Xingjiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaolin, Peng Peng, Zirong Chen, et al.. (2024). Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages. Cancer Letters. 590. 216801–216801. 11 indexed citations
2.
Han, Zhuo, Rui Wang, Zihan Zhang, et al.. (2024). The subcortical maternal complex modulates the cell cycle during early mammalian embryogenesis via 14-3-3. Nature Communications. 15(1). 8887–8887. 7 indexed citations
3.
Liang, Panpan, Hao Meng, Fangzhen Li, et al.. (2024). Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells. Nature Communications. 15(1). 40–40. 21 indexed citations
4.
Zhu, Hongtao, Dan Liu, Xiaoyu Ma, et al.. (2024). ROR1 facilitates glioblastoma growth via stabilizing GRB2 to promote c-Fos expression in glioma stem cells. Neuro-Oncology. 27(3). 695–710. 2 indexed citations
5.
Chen, Zirong, Junhong Wang, Peng Peng, et al.. (2024). Hypoxia-induced TGFBI maintains glioma stem cells by stabilizing EphA2. Theranostics. 14(15). 5778–5792. 4 indexed citations
6.
Huang, Jing, Yating Li, Yuanzhen Zhang, et al.. (2023). Toxic effect window of ovarian development in female offspring mice induced by prenatal prednisone exposure with different doses and time. Journal of Ovarian Research. 16(1). 71–71. 6 indexed citations
7.
Ma, Xiaoyu, Hongtao Zhu, Xin Chen, et al.. (2023). Dendritic cell vaccine of gliomas: challenges from bench to bed. Frontiers in Immunology. 14. 6 indexed citations
8.
Liu, Guohao, Po Zhang, Sui Chen, et al.. (2023). FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells. Neuro-Oncology. 25(10). 1788–1801. 11 indexed citations
9.
Jing, Hao, Xiangzi Han, Haidong Huang, et al.. (2023). Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma. Nature Communications. 14(1). 2262–2262. 18 indexed citations
10.
Yu, Xingjiang, et al.. (2022). Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma. Cancer Management and Research. Volume 14. 3245–3269. 8 indexed citations
11.
Peng, Peng, Hongtao Zhu, Dan Liu, et al.. (2022). TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling. Theranostics. 12(9). 4221–4236. 69 indexed citations
12.
Zhang, Po, Guohao Liu, Sui Chen, et al.. (2022). Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas. Frontiers in Immunology. 13. 824586–824586. 13 indexed citations
13.
Zhu, Hongtao, Dan Liu, Guanghui Wang, et al.. (2022). Prognostic Value and Biological Function of Galectins in Malignant Glioma. Frontiers in Oncology. 12. 834307–834307. 9 indexed citations
14.
Huang, Haidong, Xingjiang Yu, Xiangzi Han, et al.. (2021). Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression. Cell Reports. 34(1). 108522–108522. 41 indexed citations
15.
Peng, Peng, Fangling Cheng, Yuting Dong, et al.. (2021). High expression of TXNDC11 indicated unfavorable prognosis of glioma. Translational Cancer Research. 10(12). 5040–5051. 6 indexed citations
16.
Xiao, Qungen, Fangling Cheng, Po Zhang, et al.. (2020). Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling. Cancer Gene Therapy. 27(12). 878–897. 8 indexed citations
17.
Man, Jianghong, Xingjiang Yu, Haidong Huang, et al.. (2017). Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells. Cell stem cell. 22(1). 104–118.e6. 127 indexed citations
18.
Xu, Qianhua, Fengchao Wang, Yunlong Xiang, et al.. (2015). Maternal BCAS2 protects genomic integrity in mouse early embryonic development. Development. 142(22). 3943–53. 38 indexed citations
19.
Yu, Xingjiang, Zhaohong Yi, Zheng Gao, et al.. (2014). The subcortical maternal complex controls symmetric division of mouse zygotes by regulating F-actin dynamics. Nature Communications. 5(1). 4887–4887. 107 indexed citations
20.
Ni, Hua, Xingjiang Yu, Wei Lei, et al.. (2008). Progesterone regulation of glutathione S-transferase Mu2 expression in mouse uterine luminal epithelium during preimplantation period. Fertility and Sterility. 91(5). 2123–2130. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026